CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks...

How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

How Does Biotechnology Help Agriculture Sector Reap Benefits

How Does Biotechnology Help...

Biotechnology in Agriculture: Key Applications and Significance to Know

Biotechnology in Agriculture: Key...

DNA Sequencing Everything You Need to Know

DNA Sequencing Everything You Need to...

The Applications of Data Analytics in Biotechnology

The Applications of Data Analytics in...

BioCardia to Support Development of Potential Cell Therapy Products

BioCardia to Support Development of...

ProPhase Labs Expects Business Expansion with Key Promotions and Addition to Management Team

ProPhase Labs Expects Business...

Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks...

How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

How Does Biotechnology Help Agriculture Sector Reap Benefits

How Does Biotechnology Help...

Biotechnology in Agriculture: Key Applications and Significance to Know

Biotechnology in Agriculture: Key...

DNA Sequencing Everything You Need to Know

DNA Sequencing Everything You Need to...

The Applications of Data Analytics in Biotechnology

The Applications of Data Analytics in...

BioCardia to Support Development of Potential Cell Therapy Products

BioCardia to Support Development of...

ProPhase Labs Expects Business Expansion with Key Promotions and Addition to Management Team

ProPhase Labs Expects Business...

Artizan Biosciences Aims to Improve Patient Care Under New President and CEO

Life Sciences Review Life Sciences Review | Wednesday, November 10, 2021
Tweet

Dr. Bridget Martell has been named President and Chief Executive Officer of Artizan Biosciences


FREMONT, CA: “I’m honored to be leading such an exceptional, world-class, and dedicated team at Artizan as we leverage our proprietary platform-based technology to create novel differentiated small-molecule therapeutics to precisely stop microbial-driven dysregulation and inflammation that is central to many serious diseases,” states Dr. Martell. “It’s an exciting time to be part of the Companys’s efforts to enter the clinic with our lead program in inflammatory bowel disease that is supported by our strategic partnerships with Biohaven Pharmaceuticals and Brii Biosciences.” Artizan Biosciences, a biotechnology firm pioneering precision medicine for the microbiome, has hired Bridget Martell, M.A., M.D., as President and Chief Executive Officer. Dr. Martell is an accomplished biopharmaceutical executive with a track record of delivering significant accomplishments in clinical development, medical affairs, and business development across a broad range of therapeutic areas, from first-in-human to licensure and commercialization. She takes up the duties from James (Jimmy) Rosen, M.B.A., M.S.P.H.


“We are delighted to have Dr. Martell join Artizan as she brings a proven track record of developing promising science into therapeutic products that improve patient lives. 


Her bench-to-bedside experience will be extremely valuable to the Company as it works to enter the clinic,” comments Artizans Board of Directors Chairperson Christy Shaffer, Ph.D. “On behalf of the entire board, I would like to extend our gratitude to Jimmy Rosen for his contributions to Artizan. Under his leadership, the Company raised over $22 million, expanded its integrative biology laboratory team and footprint, established our proprietary microbiome system, and secured collaborations with leading biotech companies. We wish him well in his future endeavors.”


Dr. Martell brings a wealth of scientific expertise to her leadership responsibilities and has been instrumental in the success of six marketed products: Kadcyla®, Elelyso®, Intermezzo®, the trastuzumab biosimilar Ogivri®, as well as secondary indications for Pradaxa® and Sutent®. She has held executive leadership and C-suite positions at companies such as Kura Oncology, where she oversaw the rapid growth of the menin inhibitor program, and Juniper Pharmaceuticals, where she oversaw the development of a novel combined drug/device technology that was out-licensed for $131 million. Dr. Martell is now a member of the Achieve Life Sciences Board of Directors and a Venture Partner at AlleyCorps Healthcare Fund.


Weekly Brief

loading
Top 10 Leading BioTech Solution Companies - 2021
> <
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue

Read Also

Everything You Need to Know About Medical Lab Equipment and their Applications

Everything You Need to Know About Medical Lab Equipment and their Applications

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

Lung Cancer patients can see improved results with Immunotherapy along with Chemotherapy Before surgery.

Here's The List Of Top Biotech Stocks To Buy In 2022

Here's The List Of Top Biotech Stocks To Buy In 2022

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial

Efficacy and Safety Data by Entasis Therapeutics from Landmark Phase 3 Attack Trial
How Does Biotechnology Help Humans?

How Does Biotechnology Help Humans?

The several benefits Of Agricultural Genome Editing

The several benefits Of Agricultural Genome Editing

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

2027 Might See a Market Growth of Third-party Logistics at a CAGR of 7.1 percent

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare

A Week To Celebrate The Significant Role Of Clinical Lab Professionals In Healthcare
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/artizan-biosciences-aims-to-improve-patient-care-under-new-president-and-ceo-nwid-629.html